(+)‑pinoresinol‑O‑β‑D‑glucopyranoside from Eucommia ulmoides Oliver and its anti‑inflammatory and antiviral effects against influenza A (H1N1) virus infection

Li,Jing; Liang,Xiaoli; Zhou,Beixian; Chen,Xiaowei; Xie,Peifang; Jiang,Haiming; Jiang,Zhihong; Yang,Zifeng; Pan,Xiping

doi:10.3892/mmr.2018.9696

(+)‑pinoresinol‑O‑β‑D‑glucopyranoside from Eucommia ulmoides Oliver and its anti‑inflammatory and antiviral effects against influenza A (H1N1) virus infection

Authors:
- Jing Li
- Xiaoli Liang
- Beixian Zhou
- Xiaowei Chen
- Peifang Xie
- Haiming Jiang
- Zhihong Jiang
- Zifeng Yang
- Xiping Pan
View Affiliations

Affiliations: State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory Health, National Clinical Centre of Respiratory Disease, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510120, P.R. China, Department of Pharmacy, The People's Hospital of Gaozhou, Gaozhou, Guangdong 525200, P.R. China, State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, Macau 999078, P.R. China, Institute of Chinese Integrative Medicine, Guangzhou Medical University, Guangzhou, Guangdong 511436, P.R. China
Published online on: November 26, 2018 https://doi.org/10.3892/mmr.2018.9696
Pages: 563-572

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Eucommia ulmoides Oliver (Du-Zhong) is an ancient Chinese herbal remedy used for the treatment of various diseases. To date, the effects of its constituent lignans on influenza viruses remain to be elucidated. In the present study, a lignan glycoside was isolated and purified from Eucommia ulmoides Oliver. Its structures were identified via extensive spectroscopic analysis, and its antiviral and anti‑inflammatory activities, specifically against influenza viruses, were determined via a cytopathic effect (CPE) assay, plaque‑reduction assays, a progeny virus yield reduction assay, reverse transcription‑quantitative polymerase chain reaction analysis and a Luminex assay. Additionally, western blot analysis was performed to investigate the underlying mechanisms of its effects against influenza viruses. The chemical and spectroscopic methods determined the structure of lignan glycoside to be (+)‑pinoresinol‑O‑β‑D‑glucopyranoside. The CPE assay showed that (+)‑pinoresinol‑O‑β‑D‑glucopyranoside exerted inhibitory activities with 50% inhibition concentration values of 408.81±5.24 and 176.24±4.41 µg/ml against the influenza A/PR/8/34 (H1N1) and A/Guangzhou/GIRD07/09 (H1N1) strains, respectively. Its antiviral properties were confirmed by plaque reduction and progeny virus yield reduction assays. Additional mechanistic analyses indicated that the anti‑H1N1 virus‑induced effects of (+)‑pinoresinol‑O-β‑D-glucopyranoside were likely due to inactivation of the nuclear factor‑κB, p38 mitogen‑activated protein kinase and AKT signaling pathways. Furthermore, (+)‑pinoresinol‑O‑β‑D‑glucopyranoside exhibited pronounced inhibitory effects on the expression of influenza H1N1 virus‑induced pro‑inflammatory mediators, including tumor necrosis factor‑α, interleukin (IL)‑6, IL‑8 and monocyte chemoattractant protein 1. The data obtained suggest that (+)‑pinoresinol‑O‑β‑D-glucopyranoside may be a candidate drug for treating influenza H1N1 virus infection.

View Figures

View References

1	Hayden FG and Gwaltney JMJ: Viral infections. In textbook of respiratory medicine. Murray JF and Nadel JA: WB. Saunders Co.; Philadelphia: pp. 977–1035. 1994
2	Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, Nicholls JM, Ng TK, Chan KH, Lai ST, Lim WL, et al: Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet. 363:617–619. 2004. View Article : Google Scholar : PubMed/NCBI
3	Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, Thomas MJ, Basler CF, Palese P, Taubenberger JK, García-Sastre A, et al: Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature. 443:578–581. 2006.PubMed/NCBI
4	Hayden FG and de Jong MD: Emerging influenza antiviral resistance threats. J Infect Dis. 203:6–10. 2011. View Article : Google Scholar : PubMed/NCBI
5	Hai R, Schmolke M, Leyva-Grado VH, Thangavel RR, Margine I, Jaffe EL, Krammer F, Solórzano A, García-Sastre A, Palese P and Bouvier NM: Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. Nat Commun. 4:28542013. View Article : Google Scholar : PubMed/NCBI
6	Gamblin SJ and Skehel JJ: Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem. 285:28403–28409. 2010. View Article : Google Scholar : PubMed/NCBI
7	Thompson AJ and Locarnini SA: Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response. Immunol Cell Biol. 85:435–445. 2007. View Article : Google Scholar : PubMed/NCBI
8	Fukuyama S and Kawaoka Y: The pathogenesis of influenza virus infections: The contributions of virus and host factors. Curr Opin Immunol. 23:481–486. 2011. View Article : Google Scholar : PubMed/NCBI
9	Conenello GM, Zamarin D, Perrone LA, Tumpey T and Palese P: A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 3:1414–1421. 2007. View Article : Google Scholar : PubMed/NCBI
10	Högner K, Wolff T, Pleschka S, Plog S, Gruber AD, Kalinke U, Walmrath HD, Bodner J, Gattenlöhner S, Lewe-Schlosser P, et al: Macrophage-expressed IFN-β contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLoS Pathog. 9:e10031882013. View Article : Google Scholar : PubMed/NCBI
11	Hagau N, Slavcovici A, Gonganau DN, Oltean S, Dirzu DS, Brezoszki ES, Maxim M, Ciuce C, Mlesnite M, Gavrus RL, et al: Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. Crit Care. 14:R2032010. View Article : Google Scholar : PubMed/NCBI
12	Ludwig S and Planz O: Influenza viruses and the NF-kappaB signaling pathway-towards a novel concept of antiviral therapy. Biol Chem. 389:1307–1312. 2008. View Article : Google Scholar : PubMed/NCBI
13	Pinto R, Herold S, Cakarova L, Hoegner K, Lohmeyer J, Planz O and Pleschka S: Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo. Antiviral Res. 92:45–56. 2011. View Article : Google Scholar : PubMed/NCBI
14	Ehrhardt C, Marjuki H, Wolff T, Nürnberg B, Planz O, Pleschka S and Ludwig S: Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence. Cell Microbiol. 8:1336–1348. 2006. View Article : Google Scholar : PubMed/NCBI
15	Marchant D, Singhera GK, Utokaparch S, Hackett TL, Boyd JH, Luo Z, Si X, Dorscheid DR, McManus BM and Hegele RG: Toll-like receptor 4-mediated activation of p38 mitogen-activated protein kinase is a determinant of respiratory virus entry and tropism. J Virol. 84:11359–11373. 2010. View Article : Google Scholar : PubMed/NCBI
16	Xu Z, Tang M, Li Y, Liu F, Li X and Dai R: Antioxidant properties of Du-zhong (Eucommia ulmoides Oliv.) extracts and their effects on color stability and lipid oxidation of raw pork patties. J Agric Food Chem. 58:7289–7296. 2010. View Article : Google Scholar : PubMed/NCBI
17	Lee MK, Cho SY, Kim DJ, Jang JY, Shin KH, Park SA, Park EM, Lee JS, Choi MS, Lee JS, et al: Du-zhong (Eucommia ulmoides Oliv.) cortex water extract alters heme biosynthesis and erythrocyte antioxidant defense system in lead-administered rats. J Med Food. 8:86–92. 2005. View Article : Google Scholar : PubMed/NCBI
18	Hussain T, Tan B, Liu G, Oladele OA, Rahu N, Tossou MC and Yin Y: Health-promoting properties of eucommia ulmoides: A review. Evid Based Complement Alternat Med. 2016:52029082016. View Article : Google Scholar : PubMed/NCBI
19	Li L, Yan J, Hu K, Gu J, Wang JJ, Deng XL, Li H, Jing X, Li ZY, Ye QF, et al: Protective effects of Eucommia lignans against hypertensive renal injury by inhibiting expression of aldose reductase. J Ethnopharmacol. 139:454–461. 2012. View Article : Google Scholar : PubMed/NCBI
20	Reed LJ and Muench H: A simple method of estimating fifty percent endpoints. American J Epidemiol. 27:493–497. 1938. View Article : Google Scholar
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2^ΔΔCT method.
22	Sugiyama M and Kikuchi M: Studies on the constituents of osmanthus species. VII. Structures of lignan glycosides from the leaves of osmanthus asiaticus NAKAI. Chem Pharm Bull. 396:483–485. 1991. View Article : Google Scholar
23	Marjuki H, Gornitzky A, Marathe BM, Ilyushina NA, Aldridge JR, Desai G, Webby RJ and Webster RG: Influenza A virus-induced early activation of ERK and PI3K mediates V-ATPase-dependent intracellular pH change required for fusion. Cell Microbiol. 13:587–601. 2011. View Article : Google Scholar : PubMed/NCBI
24	Marjuki H, Alam MI, Ehrhardt C, Wagner R, Planz O, Klenk HD, Ludwig S and Pleschka S: Membrane accumulation of influenza A virus hemagglutinin triggers nuclear export of the viral genome via protein kinase Calpha-mediated activation of ERK signaling. J Biol Chem. 281:16707–16715. 2006. View Article : Google Scholar : PubMed/NCBI
25	Ludwig S: Targeting cell signalling pathways to fight the flu: Towards a paradigm change in anti-influenza therapy. J Antimicrob Chemother. 64:1–4. 2009. View Article : Google Scholar : PubMed/NCBI
26	Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W and Straus SE: Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest. 101:643–649. 1998. View Article : Google Scholar : PubMed/NCBI
27	de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, et al: Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 12:1203–1207. 2006. View Article : Google Scholar : PubMed/NCBI
28	Parhira S, Yang ZF, Zhu GY, Chen QL, Zhou BX, Wang YT, Liu L, Bai LP and Jiang ZH: In vitro anti-influenza virus activities of a new lignan glycoside from the latex of Calotropis gigantea. PLoS One. 9:e1045442014. View Article : Google Scholar : PubMed/NCBI
29	Mazur I, Wurzer WJ, Ehrhardt C, Pleschka S, Puthavathana P, Silberzahn T, Wolff T, Planz O and Ludwig S: Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity. Cell Microbiol. 9:1683–1694. 2007. View Article : Google Scholar : PubMed/NCBI
30	Kumar N, Xin ZT and Liang Y, Ly H and Liang Y: NF-kappaB signaling differentially regulates influenza virus RNA synthesis. J Virol. 82:9880–9889. 2008. View Article : Google Scholar : PubMed/NCBI
31	Shin YK, Liu Q, Tikoo SK, Babiuk LA and Zhou Y: Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation. J Gen Virol. 88:942–950. 2007. View Article : Google Scholar : PubMed/NCBI
32	Nencioni L, De Chiara G, Sgarbanti R, Amatore D, Aquilano K, Marcocci ME, Serafino A, Torcia M, Cozzolino F, Ciriolo MR, et al: Bcl-2 expression and p38MAPK activity in cells infected with influenza A virus: Impact on virally induced apoptosis and viral replication. J Biol Chem. 284:16004–16015. 2009. View Article : Google Scholar : PubMed/NCBI
33	Guan W, Li J, Chen Q, Jiang Z, Zhang R, Wang X, Yang Z and Pan X: Pterodontic acid isolated from laggera pterodonta inhibits viral replication and inflammation induced by influenza A virus. Molecules. 22:E17382017. View Article : Google Scholar : PubMed/NCBI
34	Bauer TT, Ewig S, Rodloff AC and Müller EE: Acute respiratory distress syndrome and pneumonia: A comprehensive review of clinical data. Clin Infect Dis. 43:748–756. 2006. View Article : Google Scholar : PubMed/NCBI
35	Bian JR, Nie W, Zang YS, Fang Z, Xiu QY and Xu XX: Clinical aspects and cytokine response in adults with seasonal influenza infection. Int J Clin Exp Med. 7:5593–5602. 2014.PubMed/NCBI
36	Yang ZF, Mok CK, Liu XQ, Li XB, He JF, Guan WD, Xu YH, Pan WQ, Chen LY, Lin YP, et al: Clinical, virological and immunological features from patients infected with re-emergent avian-origin human H7N9 influenza disease of varying severity in Guangdong province. PLoS One. 10:e01178462015. View Article : Google Scholar : PubMed/NCBI
37	Ramos I and Fernandez-Sesma A: Modulating the innate immune response to influenza A virus: Potential therapeutic use of anti-inflammatory drugs. Front Immunol. 6:3612015. View Article : Google Scholar : PubMed/NCBI
38	Droebner K, Reiling SJ and Planz O: Role of hypercytokinemia in NF-kappaB p50-deficient mice after H5N1 influenza A virus infection. J Virol. 82:11461–11466. 2008. View Article : Google Scholar : PubMed/NCBI
39	Hui KP, Lee SM, Cheung CY, Ng IH, Poon LL, Guan Y, Ip NY, Lau AS and Peiris JS: Induction of proinflammatory cytokines in primary human macrophages by influenza A virus (H5N1) is selectively regulated by IFN regulatory factor 3 and p38 MAPK. J Immunol. 182:1088–1098. 2009. View Article : Google Scholar : PubMed/NCBI
40	Lee N, Wong CK, Chan PK, Lun SW, Lui G, Wong B, Hui DS, Lam CW, Cockram CS, Choi KW, et al: Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection. Clin Infect Dis. 45:723–731. 2007. View Article : Google Scholar : PubMed/NCBI
41	N'Guessan PD, Hippenstiel S, Etouem MO, Zahlten J, Beermann W, Lindner D, Opitz B, Witzenrath M, Rosseau S, Suttorp N, et al: Streptococcus pneumoniae induced p38 MAPK- and NF-kappaB-dependent COX-2 expression in human lung epithelium. Am J Physiol Lung Cell Mol Physiol. 290:L1131–L1138. 2006. View Article : Google Scholar : PubMed/NCBI
42	Singer CA, Baker KJ, McCaffrey A, AuCoin DP, Dechert MA and Gerthoffer WT: p38 MAPK and NF-kappaB mediate COX-2 expression in human airway myocytes. Am J Physiol Lung Cell Mol Physiol. 285:L1087–L1098. 2003. View Article : Google Scholar : PubMed/NCBI
43	Lee SM, Cheung CY, Nicholls JM, Hui KP, Leung CY, Uiprasertkul M, Tipoe GL, Lau YL, Poon LL, Ip NY, et al: Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: A mechanism for the pathogenesis of avian influenza H5N1 infection. J Infect Dis. 198:525–535. 2008. View Article : Google Scholar : PubMed/NCBI
44	Carey MA, Bradbury JA, Seubert JM, Langenbach R, Zeldin DC and Germolec DR: Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection. J Immunol. 175:6878–6884. 2005. View Article : Google Scholar : PubMed/NCBI
45	Carey MA, Bradbury JA, Rebolloso YD, Graves JP, Zeldin DC and Germolec DR: Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice. PLoS One. 5:e116102010. View Article : Google Scholar : PubMed/NCBI
46	Zheng BJ, Chan KW, Lin YP, Zhao GY, Chan C, Zhang HJ, Chen HL, Wong SS, Lau SK, Woo PC, et al: Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus. Proc Natl Acad Sci USA. 105:8091–8096. 2008. View Article : Google Scholar : PubMed/NCBI
47	Coulombe F, Jaworska J, Verway M, Tzelepis F, Massoud A, Gillard J, Wong G, Kobinger G, Xing Z, Couture C, et al: Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages. Immunity. 40:554–568. 2014. View Article : Google Scholar : PubMed/NCBI